SlideShare a Scribd company logo
1 of 20
Meta-regression with DisMod-MR:
how robust is the model?
June 18, 2013
Hannah M Peterson
Post-Bachelor Fellow
Global Burden of Disease Study 2010
2
YLDs
β€’ Measures morbidity
β€’ Requires age-specific prevalence
o For 291 outcomes
o For 2 sexes
o For 187 countries
o For 3 years
3
Is negative-binomial distribution
the best choice?
DisMod-MR
4
Alternative distributions
5
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
6
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
7
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
8
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Potential experimental frameworks
β€’ Data collection
o Ideal
o Impractical
β€’ Simulation
o Impossible to know true data distribution
β€’ Out-of-sample cross validation
o Do not have to choose distribution
9
Out-of-sample cross validation
10
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
11
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
12
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
13
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
β€’ Use fit to calculate statistics
for test data
14
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
β€’ Use fit to calculate statistics
for test data
β€’ For each distribution
β€’ For 1000 test-train splits
β€’ For each disease data set
15
Comparing distributions
16
How to determine the best distribution?
Metrics of evaluation
β€’
17
Results
18
Percent of wins (%)
Distribution Bias MAE PC Total
Normal 22.1 20.6 34.6 25.7
Lognormal 29.7 13.0 36.5 26.4
Binomial 26.3 48.3 1.9 25.5
Negative-
binomial
21.9 18.1 27.1 22.4
Conclusions
β€’ Choice of distribution doesn’t greatly influence results
β€’ Best overall performance: lognormal distribution
o Contingent on method to adjust data whose value is 0
β€’ Further investigate when each distribution performs best
o Dependent on number of covariates, priors, amount of data?
19
Thank you
Hannah Peterson
peterhm@uw.edu
www.healthmetricsandevaluation.org

More Related Content

What's hot

Social Marketing Strategies in Health Care: An Introduction
Social Marketing Strategies in Health Care: An IntroductionSocial Marketing Strategies in Health Care: An Introduction
Social Marketing Strategies in Health Care: An IntroductionCTSI at UCSF
Β 
Key Message Dissections on Complementary Feeding and Assessing the Favorable ...
Key Message Dissections on Complementary Feeding and Assessing the Favorable ...Key Message Dissections on Complementary Feeding and Assessing the Favorable ...
Key Message Dissections on Complementary Feeding and Assessing the Favorable ...Mohammad Aslam Shaiekh
Β 
Introduction to Social and Behaviour Change communication (SBCC)
Introduction to Social and Behaviour Change communication (SBCC)Introduction to Social and Behaviour Change communication (SBCC)
Introduction to Social and Behaviour Change communication (SBCC)Nicol Cave
Β 
DLHS III - Dr. Suraj Chawla
DLHS III - Dr. Suraj ChawlaDLHS III - Dr. Suraj Chawla
DLHS III - Dr. Suraj ChawlaSuraj Chawla
Β 
Risk factor surveillance of Non-communicable diseases
Risk factor surveillance of Non-communicable diseasesRisk factor surveillance of Non-communicable diseases
Risk factor surveillance of Non-communicable diseasesVineetha K
Β 
Outbreak investigation
Outbreak investigationOutbreak investigation
Outbreak investigationAmandeep Kaur
Β 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1Suhail Naqvi
Β 
Prototype for health education program on utilization of family planning
Prototype for health education program on utilization of family planningPrototype for health education program on utilization of family planning
Prototype for health education program on utilization of family planningMohammad Aslam Shaiekh
Β 
National health education, information and communication center
National health education, information and communication centerNational health education, information and communication center
National health education, information and communication centerShisam Neupane
Β 
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptxMY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptxAmruthaNambiar8
Β 
Epidemiology Exercises
Epidemiology ExercisesEpidemiology Exercises
Epidemiology ExercisesMujeeb M
Β 
Investigation of Epidemic
Investigation of EpidemicInvestigation of Epidemic
Investigation of EpidemicDr. Mamta Gehlawat
Β 
Preceed proceed model of health planning
Preceed proceed model of health planningPreceed proceed model of health planning
Preceed proceed model of health planningsudarshangautam123456789
Β 
Operationalizing Clinical Excellence: Lessons Learned
Operationalizing Clinical Excellence: Lessons LearnedOperationalizing Clinical Excellence: Lessons Learned
Operationalizing Clinical Excellence: Lessons LearnedHuron Consulting Group
Β 
Health communication
Health communicationHealth communication
Health communicationZeal1284
Β 
Comminity nutritional assessment
Comminity nutritional assessmentComminity nutritional assessment
Comminity nutritional assessmentAdnaAbdisalam
Β 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigationshabna lekha
Β 
epidemic_preparedness_l.ppt
epidemic_preparedness_l.pptepidemic_preparedness_l.ppt
epidemic_preparedness_l.pptPhcNelliyampathy
Β 

What's hot (20)

Social Marketing Strategies in Health Care: An Introduction
Social Marketing Strategies in Health Care: An IntroductionSocial Marketing Strategies in Health Care: An Introduction
Social Marketing Strategies in Health Care: An Introduction
Β 
Key Message Dissections on Complementary Feeding and Assessing the Favorable ...
Key Message Dissections on Complementary Feeding and Assessing the Favorable ...Key Message Dissections on Complementary Feeding and Assessing the Favorable ...
Key Message Dissections on Complementary Feeding and Assessing the Favorable ...
Β 
Introduction to Social and Behaviour Change communication (SBCC)
Introduction to Social and Behaviour Change communication (SBCC)Introduction to Social and Behaviour Change communication (SBCC)
Introduction to Social and Behaviour Change communication (SBCC)
Β 
DLHS III - Dr. Suraj Chawla
DLHS III - Dr. Suraj ChawlaDLHS III - Dr. Suraj Chawla
DLHS III - Dr. Suraj Chawla
Β 
Who anthroplus manual
Who anthroplus manualWho anthroplus manual
Who anthroplus manual
Β 
Risk factor surveillance of Non-communicable diseases
Risk factor surveillance of Non-communicable diseasesRisk factor surveillance of Non-communicable diseases
Risk factor surveillance of Non-communicable diseases
Β 
Outbreak investigation
Outbreak investigationOutbreak investigation
Outbreak investigation
Β 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1
Β 
Prototype for health education program on utilization of family planning
Prototype for health education program on utilization of family planningPrototype for health education program on utilization of family planning
Prototype for health education program on utilization of family planning
Β 
National health education, information and communication center
National health education, information and communication centerNational health education, information and communication center
National health education, information and communication center
Β 
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptxMY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
Β 
Epidemiology Exercises
Epidemiology ExercisesEpidemiology Exercises
Epidemiology Exercises
Β 
Investigation of Epidemic
Investigation of EpidemicInvestigation of Epidemic
Investigation of Epidemic
Β 
Preceed proceed model of health planning
Preceed proceed model of health planningPreceed proceed model of health planning
Preceed proceed model of health planning
Β 
Operationalizing Clinical Excellence: Lessons Learned
Operationalizing Clinical Excellence: Lessons LearnedOperationalizing Clinical Excellence: Lessons Learned
Operationalizing Clinical Excellence: Lessons Learned
Β 
Health communication
Health communicationHealth communication
Health communication
Β 
NACP
NACPNACP
NACP
Β 
Comminity nutritional assessment
Comminity nutritional assessmentComminity nutritional assessment
Comminity nutritional assessment
Β 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
Β 
epidemic_preparedness_l.ppt
epidemic_preparedness_l.pptepidemic_preparedness_l.ppt
epidemic_preparedness_l.ppt
Β 

More from Institute for Health Metrics and Evaluation - University of Washington

More from Institute for Health Metrics and Evaluation - University of Washington (20)

Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation PlanSalud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Β 
Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...
Β 
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Β 
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation PlanSalud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Β 
Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...
Β 
Salud MesoamΓ©rica Initiative: Select results from the baseline measurement
Salud MesoamΓ©rica Initiative: Select results from the baseline measurementSalud MesoamΓ©rica Initiative: Select results from the baseline measurement
Salud MesoamΓ©rica Initiative: Select results from the baseline measurement
Β 
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Β 
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Β 
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Β 
The Global Fund Prospective Country Evaluation
The Global Fund Prospective Country EvaluationThe Global Fund Prospective Country Evaluation
The Global Fund Prospective Country Evaluation
Β 
Prospective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis FindingsProspective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis Findings
Β 
Global Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findingsGlobal Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findings
Β 
Expected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking pointsExpected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking points
Β 
Global Health Financing
Global Health FinancingGlobal Health Financing
Global Health Financing
Β 
Maternal and Child Mortality in the United States
Maternal and Child Mortality in the United StatesMaternal and Child Mortality in the United States
Maternal and Child Mortality in the United States
Β 
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Β 
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi ArabiaChronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Β 
Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015
Β 
Understanding the costs of and constraints to health service delivery in Ghana
Understanding the costs of and constraints to health service delivery in GhanaUnderstanding the costs of and constraints to health service delivery in Ghana
Understanding the costs of and constraints to health service delivery in Ghana
Β 
ABCE: Understanding the costs of and constraints to health service delivery ...
ABCE: Understanding the costs of and constraints to health service delivery ...ABCE: Understanding the costs of and constraints to health service delivery ...
ABCE: Understanding the costs of and constraints to health service delivery ...
Β 

Recently uploaded

costume and set research powerpoint presentation
costume and set research powerpoint presentationcostume and set research powerpoint presentation
costume and set research powerpoint presentationphoebematthew05
Β 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
Β 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions
Β 
Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...
Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...
Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...Patryk Bandurski
Β 
Bluetooth Controlled Car with Arduino.pdf
Bluetooth Controlled Car with Arduino.pdfBluetooth Controlled Car with Arduino.pdf
Bluetooth Controlled Car with Arduino.pdfngoud9212
Β 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
Β 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraDeakin University
Β 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphNeo4j
Β 
Snow Chain-Integrated Tire for a Safe Drive on Winter Roads
Snow Chain-Integrated Tire for a Safe Drive on Winter RoadsSnow Chain-Integrated Tire for a Safe Drive on Winter Roads
Snow Chain-Integrated Tire for a Safe Drive on Winter RoadsHyundai Motor Group
Β 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
Β 
APIForce Zurich 5 April Automation LPDG
APIForce Zurich 5 April  Automation LPDGAPIForce Zurich 5 April  Automation LPDG
APIForce Zurich 5 April Automation LPDGMarianaLemus7
Β 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsAndrey Dotsenko
Β 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
Β 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
Β 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machinePadma Pradeep
Β 
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024BookNet Canada
Β 
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr LapshynFwdays
Β 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
Β 

Recently uploaded (20)

costume and set research powerpoint presentation
costume and set research powerpoint presentationcostume and set research powerpoint presentation
costume and set research powerpoint presentation
Β 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
Β 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food Manufacturing
Β 
Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...
Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...
Integration and Automation in Practice: CI/CD in MuleΒ Integration and Automat...
Β 
Bluetooth Controlled Car with Arduino.pdf
Bluetooth Controlled Car with Arduino.pdfBluetooth Controlled Car with Arduino.pdf
Bluetooth Controlled Car with Arduino.pdf
Β 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
Β 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning era
Β 
Hot Sexy call girls in Panjabi Bagh πŸ” 9953056974 πŸ” Delhi escort Service
Hot Sexy call girls in Panjabi Bagh πŸ” 9953056974 πŸ” Delhi escort ServiceHot Sexy call girls in Panjabi Bagh πŸ” 9953056974 πŸ” Delhi escort Service
Hot Sexy call girls in Panjabi Bagh πŸ” 9953056974 πŸ” Delhi escort Service
Β 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
Β 
Snow Chain-Integrated Tire for a Safe Drive on Winter Roads
Snow Chain-Integrated Tire for a Safe Drive on Winter RoadsSnow Chain-Integrated Tire for a Safe Drive on Winter Roads
Snow Chain-Integrated Tire for a Safe Drive on Winter Roads
Β 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
Β 
APIForce Zurich 5 April Automation LPDG
APIForce Zurich 5 April  Automation LPDGAPIForce Zurich 5 April  Automation LPDG
APIForce Zurich 5 April Automation LPDG
Β 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Β 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
Β 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
Β 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machine
Β 
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Transcript: #StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
Β 
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
Β 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
Β 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Β 

Meta-regression with DisMod-MR: how robust is the model?

Editor's Notes

  1. Global Burden of Disease Study 2010 (GBD)-huge endeavor to measure health loss from disease, injuries, and risk using the Disability Adjusted Life Year (DALY)-coarsely described in the this 18-step process-I am just going to focus on a small subsection, the calculation of DALYs for injuries and disease-further narrow focus to the calculation of YLDsfigure:Murray, Ezzati, et. al. 2013. β€œGBD 2010: design, definitions, and metrics”. The Lancet. 380(9859):2063-2066.
  2. -YLDsmeasure morbidity, or years lived in less than full health-the YLD calculation needs age-specific prevalence estimates, for GBD, this means ---for 291 outcomes ---for 2 sexes---for 187 countries---for 3 years-however prevalence data is often less than ideal, -examples all available data in Western Europe for GDB2010 Study---sparse (fungal diseases) ---noisy (lower back pain) ---sparse and noisy (cannabis dependence data)-to calculate age-specific prevalence, used a tool called DisMod-MR
  3. -DisMod-MR is designed to address missing data and inconsistency ---used epidemiologic data and covariate data to calculate the age-specific prevalence based on a negative-binomial distribution---assumes all epidemiological data follows a negative-binomial distribution-is it really the best distribution to model the epidemiologic data?figure: Vos, Flaxman, et. al. 2013. β€œYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010”. The Lancet. 380(9859):2163-2196.
  4. Normalπœ‡=π‘šπ‘’π‘Žπ‘›πœŽ=π‘ π‘‘π‘Žπ‘›π‘‘π‘Žπ‘Ÿπ‘‘Β π‘‘π‘’π‘£π‘–π‘Žπ‘‘π‘–π‘œπ‘›-mathematically convenient-PROBLEM: allows negative estimates of prevalence, physiological impossibleNegative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  5. Lognormalπœ‡=π‘šπ‘’π‘Žπ‘›πœŽ=π‘ π‘‘π‘Žπ‘›π‘‘π‘Žπ‘Ÿπ‘‘Β π‘‘π‘’π‘£π‘–π‘Žπ‘‘π‘–π‘œπ‘›-bounds estimates at 0-PROBLEM: doesn’t allow prevalence to be 0---can’t take the log of 0-changed values of 0 to be 1 observation-other options would be to use an offset lognormal distribution-but somehow, have to work around estimates of 0Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  6. Binomial-which Dr. Flaxman already discussed-discrete model𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘ Β π‘‘π‘’π‘ π‘‘π‘’π‘‘π‘₯=π‘‘π‘’π‘ π‘‘π‘’π‘‘Β π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  7. Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘ Β π‘‘π‘’π‘ π‘‘π‘’π‘‘π‘₯=π‘‘π‘’π‘ π‘‘π‘’π‘‘Β π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to varyNegative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  8. Several ways to test which distribution is the best-ideal-data collection---actually go to country (region??) and measure age-specific prevalence---expensiveimpractical-simulation---great for testing, not for validation---problem: have to choose from what distribution the simulated data/measurements come------this is what we’re testing------simulation can showwhatever you want------impossible to know from what distribution measurement-out-of-sample cross validation---way to evaluate and compare distributions---shows how model performs in real life------can test out-of-sample predictive validity------don’t have to choose data distribution---concerns------unstable with sparse data-----------not just the epidemiologic data-----------also covariates and priors
  9. This experiment-57 different disease data sets---met inclusion criteria of more than 4 prevalence points in western europe---not a birth-condition meaning prevalence data is only at age 0-restricted to Western EuropeTo explain out-of-sample cross validation usedan example from GBD2010fungal diseases
  10. Randomly select 25% of data to withhold as test datatest data used to evaluate results
  11. Test data is withheld from DisMod-MR
  12. And the remaining data is fit
  13. From the fit, these estimates are compared to the test dataThis comparison of the estimate to the test data is where the statistics are calculatedthe same test-train split fits are created for each of the distribution so we can make a comparison
  14. -process repeated 1000 times with different test-train splits-repeated for 57 different disease data set---met inclusion criteria of more than 4 prevalence points in western europe---not a birth-condition meaning prevalence data is only at age 057 disease/injury conditions met this criteria
  15. metrics that capture different aspects of model performanceWant a model that is precise, accurate, well-calibrated -precise (bias)---measures average difference between the test data and prediction-accurate (median absolute error-MAE)---measure of overall error---many small errors create one large number---sensitive to mean and scale---less sensitive to outliers-calibrated (percent coverage-PC)---calibrated, meaning that our estimates are in the correct range of values------if we aim for 95% uncertainty, we expect 95% of our estimates to be good------more than that and the model is over confident------less than that and the model isn’t very good---percent of time the uncertainty interval of the prediction contains the observation---sensitive to discrete distributionsto determine which distribution performed the best, counted the the winner for each disease data set and split
  16. -for different metrics different distributions are superior---makes sense, since each distribution has it’s strengths and weaknesses---smallest bias: lognormal---minimum MAE: binomial---closest percent coverage: lognormal-concern about most frequent results and not raw numbers:---differences are small ------bias, ten-thousandths (E-4), average bias is negative binomial------mae, hundreds-overall winner: lognormal
  17. -previously saw, distribution choice doesn’t greatly influence DisMod-MR’s estimates of age-specific prev-results differ by metric-Best overall performance: lognormal distribution---STRESS:Contingent on method to adjust data whose value is 0-Further investigate when each distribution performs best---Dependent on number of covariates, priors, amount of data?DisMod-MR is robust in that choice of distribution for epidemiological values does not greatly influence estimates, but one distribution performs the best most frequently